Newborn bloodspot screening: setting the Australian national policy agenda

Craig A White and Karla Lister
Med J Aust 2014; 201 (10): . || doi: 10.5694/mja14.01167
Published online: 17 November 2014

To the Editor: Maxwell and O'Leary's article1 and Wiltshire and Cameron's letter2 provide insights into the current issues facing newborn bloodspot screening (NBS) in Australia. It is clear that we have world-class NBS programs, but there is a lack of national policy guidance agreed on by governments. It has been argued that this has affected the programs' capacity to respond to the changing environment in which they operate.1,3,4 There is a need for clear national policies to support the programs' continued success and growth, and a way to assess the benefits and harms of screening additional conditions through NBS.5 Since the aforementioned articles were published, there has been substantial progress towards achieving these goals.

  • Craig A White1,2
  • Karla Lister1

  • 1 Office of Population Health Genomics, WA Health, Perth, WA.
  • 2 Department of Health and Human Services, Hobart, TAS.

Competing interests:

No relevant disclosures.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.